We were honored today by the visit of His Majesty King Abdullah II on the occasion of the 50th anniversary of the founding of Dar Aldawa Company

During the visit, His Majesty listened to a briefing by Chairman of the Board Akram Jarrab on the company’s achievements and its role in enhancing pharmaceutical security locally and globally.

The Chairman, in the presence of the company’s board members, spoke about the development of manufacturing and supply chains, which now include 20 production lines distributed across four factories in Jordan and three in Algeria.

CEO Khaled Harb provided an explanation, stating that the company achieved total sales of approximately $111 million last year, including exports valued at $87 million.

Harb also discussed the company’s expansion plans, noting that it recently obtained a license to manufacture pharmaceuticals in Saudi Arabia and has begun establishing a factory there. He affirmed the company’s alignment with the Economic Modernization Vision, which aims to increase growth rates and provide job opportunities for Jordanians.